Morgan Stanley’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62M Buy
1,860,453
+608,049
+49% +$20.4M ﹤0.01% 1876
2025
Q4
$43.3M Sell
1,252,404
-327,949
-21% -$10.5M ﹤0.01% 2222
2025
Q3
$43M Buy
1,580,353
+126,976
+9% +$3.07M ﹤0.01% 2140
2025
Q2
$30.5M Sell
1,453,377
-233,211
-14% -$4.47M ﹤0.01% 2398
2025
Q1
$27.6M Buy
1,686,588
+131,508
+8% +$2.8M ﹤0.01% 2359
2024
Q4
$40M Buy
1,555,080
+1,194,443
+331% +$33.8M ﹤0.01% 2046
2024
Q3
$11.4M Sell
360,637
-423,488
-54% -$16.1M ﹤0.01% 3327
2024
Q2
$27.5M Buy
784,125
+20,507
+3% +$812K ﹤0.01% 2325
2024
Q1
$33.5M Sell
763,618
-1,702,924
-69% -$73.2M ﹤0.01% 2139
2023
Q4
$87.8M Buy
2,466,542
+2,233,766
+960% +$66.7M ﹤0.01% 1859
2023
Q3
$6.28M Sell
232,776
-119,790
-34% -$3.04M ﹤0.01% 3551
2023
Q2
$8.29M Buy
352,566
+261,814
+288% +$5.38M ﹤0.01% 3342
2023
Q1
$1.25M Buy
90,752
+32,635
+56% +$544K ﹤0.01% 4734
2022
Q4
$1.06M Buy
58,117
+9,085
+19% +$153K ﹤0.01% 4840
2022
Q3
$732K Sell
49,032
-37,023
-43% -$481K ﹤0.01% 5067
2022
Q2
$1.19M Sell
86,055
-34,784
-29% -$387K ﹤0.01% 4911
2022
Q1
$1.35M Buy
120,839
+81,646
+208% +$1.2M ﹤0.01% 4785
2021
Q4
$926K Buy
39,193
+11,810
+43% +$274K ﹤0.01% 5130
2021
Q3
$698K Buy
27,383
+15,825
+137% +$370K ﹤0.01% 5302
2021
Q2
$243K Buy
11,558
+11,327
+4,903% +$233K ﹤0.01% 5914
2021
Q1
$6K Sell
231
-11,719
-98% -$226K ﹤0.01% 7059
2020
Q4
$167K Buy
11,950
+7,341
+159% +$99.5K ﹤0.01% 5678
2020
Q3
$58K Sell
4,609
-2,107
-31% -$26.1K ﹤0.01% 5673
2020
Q2
$96K Buy
6,716
+6,192
+1,182% +$48.8K ﹤0.01% 5418
2020
Q1
$2K Sell
524
-376
-42% -$2.66K ﹤0.01% 6385
2019
Q4
$7K Buy
+900
New +$6.42K ﹤0.01% 6344

Other funds holding IDYA